Gloshell
Ingredients

Ingredient Dictionary

POTASSIUM BROMATE

Potassium bromate can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).

Molecular structure

Definition

Potassium bromate can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).

Source: PubChem

US FDA substance register · UNII 04MB35W6ZA · registered name POTASSIUM BROMATE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Oxidises other ingredientsOXIDISING

Safety & regulatory references

Banned
Argentina · ASEAN · Brazil · Canada · China · European Union · South Korea · Taiwan · United Kingdom

Source: ASEAN Cosmetic Directive · EU Cosmetics Regulation · MFDS (Korea) cosmetic regulatory information · Taiwan FDA cosmetic ingredients · UK cosmetics regulations (OPSS)

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

EU Cosmetics Regulation, Annex II (prohibited substances), entry 461

Source: EU prohibited substances (Annex II)

Health Canada Cosmetic Ingredient Hotlist · prohibited in cosmetics

Source: Health Canada Cosmetic Ingredient Hotlist

Restriction II/461 · Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

Reviewed by CIR: Annual Review of Cosmetic Ingredient Safety Assessments: 2007-2010

Source: US Cosmetic Ingredient Review (CIR)

Reviewed by CIR: Final Report on the Safety Assessment of Sodium Bromate and Potassium Bromate

Source: US Cosmetic Ingredient Review (CIR)

More data — names, identifiers, properties, test records, literature

Names & identifiers

POTASSIUM BROMATEINCI포타슘브로메이트Korean label name (MFDS standard)Bromic acid, potassium saltSynonym
CAS No.chemical registry number
7758-01-2
EC No.EU chemical inventory number
231-829-8
DTXSIDUS EPA chemical ID
DTXSID6020195
DTXCIDUS EPA compound ID
DTXCID40195
IUPAC
Potassium bromate
Molecular formula
BrKO3
Molecular weight
166.999 g/mol

Measured properties

Appearance
Potassium bromate appears as a white crystalline solid. · White solid, [Merck Index] White odorless crystalline solid, Soluble in water, [MSDSonline]
Odour
Odorless
Boiling point
Decomposes at 698 °F (NTP, 1992)
Melting point
662 °F (NTP, 1992) · 350 °C, decomposes at 370 °C with evolution of oxygen.
Solubility
10 to 50 mg/mL at 66 °F (NTP, 1992) · Solubility (g/100 g water): 3.1 at 0 °C, 6.9 at 20 °C, 13.1 at 40 °C, 22.2 at 60 °C, 33.9 at 80 °C, 49.7 at 100 °C
Density
3.27 (NTP, 1992) - Denser than water, will sink · 3.27 g/cu cm at 17.5 °C
Stability
Stable under recommended storage conditions. · /Potassium bromate/ mixtures with sulfur are unstable, and may ignite some hours after preparation, depending on the state of subdivision and atmospheric humidity.
pH
The pH of a 1:20 aqueous solution is between 5 and 9
Colour
white
Melting/freezing point
350 ℃
Initial boiling point and range
370 ℃
Water solubility
75000 ㎎/ℓ
Relative density
3.218
Molecular weight
167.01

Values measured on the substance itself. The KOSHA data are a reference for writing and reviewing safety data sheets, not a specification for a commercial raw material.

Source: PubChem · KOSHA safety data sheets (Korea)

What products actually use it for

What the 5 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Oxidizing agent2
  • Food preservative (EPA)1
  • Leavening agent (EPA)1
  • Filler1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

4 skin studies and 2 eye studies are on record.

Classed as low1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 6 studies
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
  • Category 6.3A (Category 2)
    Skin Irritation · Read Across
  • Classification not possible
    Skin Irritation · Screening
  • Classification not possible
    Skin Sensitization · Screening
  • Category 6.4A (Category 2A)
    Eye Irritation · Read Across
  • Category 2B
    Eye Irritation · Screening

Source: US EPA CompTox dashboard

Related literature

Linked databases 25